CONMED Corp — Director's Dealing 2025

Jun 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2025-06-02

Reporting Person: Concannon Brian (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-03	Common Stock	M	479	—	Acquired	10116	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-02	Options To Purchase Common Stock	$55.38	A	8061	Acquired	2035-06-02	Common Stock (8061)	Direct
2025-06-02	RSUs (Restricted Stock Units)	$0	A	668	Acquired	2035-06-02	Common Stock (668)	Direct
2025-06-03	RSUs (Restricted Stock Units)	$0	M	479	Disposed	2034-06-03	Common Stock (479)	Direct

Footnotes

F1: The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.